Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: Relevance as an animal model of mania

Andreazza, 2007, Serum S100B and antioxidant enzymes in bipolar patients, J Psychiatr Res, 41, 523, 10.1016/j.jpsychires.2006.07.013 Andreazza, 2008, Effects of mood stabilizers on DNA damage in an animal model of mania, J Psychiatry Neurosci, 33, 516 Andreazza, 2009, 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder, J Psychiatry Neurosci, 34, 263 Archer, 1973, Tests for emotionality in rats and mice: a review, Anim Behav, 21, 205, 10.1016/S0003-3472(73)80065-X Beauchaine, 2011, The effects of allostatic load on neural systems subserving motivation, mood regulation, and social affiliation, Dev Psychopathol, 23, 975, 10.1017/S0954579411000459 Beaulieu, 2011, The physiology, signaling, and pharmacology of dopamine receptors, Pharmacol Rev, 63, 182, 10.1124/pr.110.002642 Behrens, 2009, Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?, Neuropharmacology, 57, 193, 10.1016/j.neuropharm.2009.06.002 Berk, 2009, Neuroprogression: pathways to progressive brain changes in bipolar disorder, Int J Neuropsychopharmacol, 12, 441, 10.1017/S1461145708009498 Berk, 2007, Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder, Acta Psychiatr Scand Suppl, 434, 41, 10.1111/j.1600-0447.2007.01058.x Berk, 2011, Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors, Neurosci Biobehav Rev, 35, 804, 10.1016/j.neubiorev.2010.10.001 Berman, 1999, Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease, J Neurochem, 73, 1127, 10.1046/j.1471-4159.1999.0731127.x Breuillaud, 2012, Deletion of CREB-regulated transcription coactivator 1 induces pathological aggression, depression-related behaviors, and neuroplasticity genes dysregulation in mice, Biol Psychiatry, 14, 14 da-Rosa, 2012, Effects of lithium and valproate on oxidative stress and behavioral changes induced by administration of m-AMPH, Psychiatry Res, 17, 17 das Neves Duarte, 2012, N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development, Biol Psychiatry, 71, 1006, 10.1016/j.biopsych.2011.07.035 Dennehy, 2011, Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), J Affect Disord, 133, 423, 10.1016/j.jad.2011.04.036 Dent, 2012, Dose-dependent effects of prefrontal dopamine on behavioral state in rats, Behav Neurosci, 27, 27 Draper, 1993, A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials, Free Radic Biol Med, 15, 353, 10.1016/0891-5849(93)90035-S Drevets, 2001, Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria, Biol Psychiatry, 49, 81, 10.1016/S0006-3223(00)01038-6 Einat, 2006, Modelling facets of mania — new directions related to the notion of endophenotypes, J Psychopharmacol, 20, 714, 10.1177/0269881106060241 Ellman, 1959, Tissue sulfhydryl groups, Arch Biochem Biophys, 82, 70, 10.1016/0003-9861(59)90090-6 Fiorino, 1999, Facilitation of sexual behavior and enhanced dopamine efflux in the nucleus accumbens of male rats after d-amphetamine-induced behavioral sensitization, J Neurosci, 19, 456, 10.1523/JNEUROSCI.19-01-00456.1999 Flaisher-Grinberg, 2010, Models of mania: from facets to domains and from animal models to model animals, J Psychopharmacol, 24, 437, 10.1177/0269881108097905 Fleckenstein, 2007, New insights into the mechanism of action of amphetamines, Annu Rev Pharmacol Toxicol, 47, 681, 10.1146/annurev.pharmtox.47.120505.105140 Frey, 2006, Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania, Life Sci, 79, 281, 10.1016/j.lfs.2006.01.002 Frey, 2006, Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania, Neurochem Res, 31, 699, 10.1007/s11064-006-9070-6 Frey, 2006, Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania, J Psychiatry Neurosci, 31, 326 Graham, 1978, Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro, Mol Pharmacol, 14, 644 Harrison-Read, 2009, Models of mania and antimanic drug actions: progressing the endophenotype approach, J Psychopharmacol, 23, 334, 10.1177/0269881108089840 Hopkins, 2000, Serum lithium levels and the outcome of maintenance therapy of bipolar disorder, Bipolar Disord, 2, 174, 10.1034/j.1399-5618.2000.020304.x Jasinski, 2009, Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse, J Psychopharmacol, 23, 419, 10.1177/0269881109103113 Kapczinski, 2008, Allostatic load in bipolar disorder: implications for pathophysiology and treatment, Neurosci Biobehav Rev, 32, 675, 10.1016/j.neubiorev.2007.10.005 Kleijn, 2012, Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation, Neurochem Int, 60, 791, 10.1016/j.neuint.2012.03.002 Ko, 2012, Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging, Neuroscientist, 18, 149, 10.1177/1073858411401413 Kolar, 2008, Treatment of adults with attention-deficit/hyperactivity disorder, Neuropsychiatr Dis Treat, 4, 107 Lenaz, 2000, Mitochondrial bioenergetics in aging, Biochim Biophys Acta, 15, 2 Lipska, 2000, To model a psychiatric disorder in animals: schizophrenia as a reality test, Neuropsychopharmacology, 23, 223, 10.1016/S0893-133X(00)00137-8 Macedo, 2012, Effects of alpha-lipoic acid in an animal model of mania induced by d-amphetamine, Bipolar Disord, 14, 707, 10.1111/j.1399-5618.2012.01046.x Machado-Vieira, 2007, Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects, Neurosci Lett, 421, 33, 10.1016/j.neulet.2007.05.016 Mattingly, 2010, Lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of ADHD in children and adults, CNS Spectr, 15, 315, 10.1017/S1092852900027541 McIntyre, 2012, Managing medical and psychiatric comorbidity in individuals with major depressive disorder and bipolar disorder, Ann Clin Psychiatry, 24, 163 Nestler, 2010, Animal models of neuropsychiatric disorders, Nat Neurosci, 13, 1161, 10.1038/nn.2647 NIH, 1996 Pennick, 2010, Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine, Neuropsychiatr Dis Treat, 6, 317, 10.2147/NDT.S9749 Post, 2007, Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena, Neurosci Biobehav Rev, 31, 858, 10.1016/j.neubiorev.2007.04.003 Riegel, 2009, Animal model of mania induced by ouabain: evidence of oxidative stress in submitochondrial particles of the rat brain, Neurochem Int, 55, 491, 10.1016/j.neuint.2009.05.003 Rowley, 2012, Lisdexamfetamine and immediate release d-amfetamine — differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity, Neuropharmacology, 63, 1064, 10.1016/j.neuropharm.2012.07.008 Scheffer, 2005, Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium, Am J Psychiatry, 162, 58, 10.1176/appi.ajp.162.1.58 Soreca, 2008, Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder, J Psychiatr Res, 42, 956, 10.1016/j.jpsychires.2007.10.009 Steullet, 2010, Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors, J Neurosci, 30, 2547, 10.1523/JNEUROSCI.3857-09.2010 Yang, 2002, Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(−/−) knockout mouse. Novel model system for a severely compromised oxidative stress response, J Biol Chem, 277, 49446, 10.1074/jbc.M209372200